An update to the language found under M0030 (Start of Care Date) was included in the draft version of the OASIS-E1 instrument, released in May. OASIS-E1 is set to take effect Jan. 1, 2025.
If your EMR flags medications as being at risk for interactions, it doesn’t mean that you should capture that situation in the OASIS drug regimen review items under M2001.
It is important to accurately assess for this item as missing some statements on M1033 can have an impact on both revenue and OASIS outcomes.
Clinicians should familiarize themselves with what is considered high-risk for M2010 (Patient/Caregiver High-Risk Drug Education) as this may not always be the same as the high-risk categories in N0415 (High-Risk Drug Classes: Use and Indication).
The complexity of assessing safe ability with M2020 (Management of oral medications) can often be a challenging task for clinicians, especially since the guidance has changed over time.
CMS has responded by email to a question that was recently submitted regarding how to accurately score OASIS item M1860 (Ambulation/locomotion).
An AV fistula, whether it is being accessed or not, does not meet the definition of IV Access for O0110O1 (Special Treatments, Procedures and Programs; Other - IV Access), CMS clarified in response to a question in the January 2024 quarterly OASIS Q&As. 
When clinicians respond to OASIS-E’s C1310 (Signs and Symptoms of Delirium), ensure they know the difference between aspects of this item such as inattention versus altered consciousness. 
Try using words such as aching, burning or hurting to help patients understand what is being asked for the OASIS-E items J0510-J0530 (Pain interview).
One of the most common mistakes during a quality review with M1870 is mistaking “meal set-up” as “meal prep."


User Name: